finding that “there is nothing improper in the chief special master’s decision to refer to damages for pain and suffering awarded in other cases as an aid in determining the proper amount of damages in this case.”
How later courts described this case
- finding that “there is nothing improper in the chief special master’s decision to refer to damages for pain and suffering awarded in other cases as an aid in determining the proper amount of damages in this case.”
Written by the judges who cited it.
The opinion
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 21-2310V
JOEY DYLLA, Chief Special Master Corcoran
Petitioner, Filed: February 27, 2024
v.
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for Petitioner.
Mallori Browne Openchowski, U.S. Department of Justice, Washington, DC, for
Respondent.
DECISION AWARDING DAMAGES1
On December 20, 2021, Joey Dylla filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that she suffered Guillain-Barré syndrome (“GBS”), a
defined Table injury, after receiving an influenza (“flu”) vaccine on September 19, 2019.
Petition at 1 n.2, ¶¶ 2, 26. The case was assigned to the Special Processing Unit (“SPU”)
of the Office of Special Masters. After Respondent conceded entitlement, the parties were
unable to resolve damages on their own,3 so I ordered briefing on the matter.
1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government
Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In
accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other
information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I
agree that the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2018).
3 Almost ten months after Petitioner was determined to be entitled to compensation, the parties informed
me that they had reached an impasse in their damages discussions and requested that I set a briefing
schedule. Status Report, filed Sept. 11, 2023, ECF No. 55.
For the reasons set forth below, I find that Petitioner is entitled to an award of
damages in the amount $170,000.00 for pain and suffering, plus $21,480.00 for the
costs of renovations to her home. The parties have agreed Petitioner is also entitled
to $7,506.81 for past unreimbursed expenses, and $1,408.50 for the cost of her
future medication.
I. Legal Standard
Compensation awarded pursuant to the Vaccine Act shall include “[f]or actual and
projected pain and suffering and emotional distress from the vaccine-related injury, an
award not to exceed $250,000.” Section 15(a)(4). Additionally, a petitioner may recover
“actual unreimbursable expenses incurred before the date of judgment award such
expenses which (i) resulted from the vaccine-related injury for which petitioner seeks
compensation, (ii) were incurred by or on behalf of the person who suffered such injury,
and (iii) were for diagnosis, medical or other remedial care, rehabilitation . . . determined
to be reasonably necessary.” Section 15(a)(1)(B). The petitioner bears the burden of proof
with respect to each element of compensation requested. Brewer v. Sec’y of Health &
Hum. Servs., No. 93-0092V, 1996 WL 147722, at *22-23 (Fed. Cl. Spec. Mstr. Mar. 18,
1996).
There is no mathematic formula for assigning a monetary value to a person’s pain
and suffering and emotional distress. I.D. v. Sec’y of Health & Hum. Servs., No. 04-1593V,
2013 WL 2448125, at *9 (Fed. Cl. Spec. Mstr. May 14, 2013) (“[a]wards for emotional
distress are inherently subjective and cannot be determined by using a mathematical
formula”); Stansfield v. Sec’y of Health & Hum. Servs., No. 93-0172V, 1996 WL 300594,
at *3 (Fed. Cl. Spec. Mstr. May 22, 1996) (“the assessment of pain and suffering is
inherently a subjective evaluation”). Factors to be considered when determining an award
for pain and suffering include: 1) awareness of the injury; 2) severity of the injury; and 3)
duration of the suffering. I.D., 2013 WL 2448125, at *9 (quoting McAllister v. Sec’y of
Health & Hum. Servs., No 91-1037V, 1993 WL 777030, at *3 (Fed. Cl. Spec. Mstr. Mar.
26, 1993), vacated and remanded on other grounds, 70 F.3d 1240 (Fed. Cir. 1995)).
I may also consider prior pain and suffering awards to aid my resolution of the
appropriate amount of compensation for pain and suffering in this case. See, e.g., Doe
34 v. Sec’y of Health & Hum. Servs., 87 Fed. Cl. 758, 768 (2009) (finding that “there is
nothing improper in the chief special master’s decision to refer to damages for pain and
suffering awarded in other cases as an aid in determining the proper amount of damages
in this case.”). And, of course, I may rely on my own experience (along with my
2
predecessor Chief Special Masters) adjudicating similar claims.4 Hodges v. Sec’y of
Health & Hum. Servs., 9 F.3d 958, 961 (Fed. Cir. 1993) (noting that Congress
contemplated the special masters would use their accumulated expertise in the field of
vaccine injuries to judge the merits of individual claims).
II. The Parties’ Arguments
The parties agree that Petitioner is entitled to $7,506.81 for past unreimbursed
medical expenses, and $1,408.50 as a lump sum to cover the out-of-pocket cost of future
medication (Gabapentin). Petitioner’s Memorandum in Support of Damages (“Pet. Brief”),
filed Oct. 26, 2023, at 20-22, ECF No. 58. Petitioner also seeks $21,480.00 to cover the
cost of renovating a half-bath to include a walk-in shower, as recommended by her
neurologists, and $180,000.00 for past and future pain and suffering. Id. at 22-24, 40; see
Exhibit 43, filed Oct. 26, 2023, ECF No. 56-3 (estimates for and pictures of these
renovations). Although she maintains that she retired earlier than expected from her job
- as a financial advisor and outside salesman for a credit union - due to her GBS illness,
Petitioner does not seek any lost wages award. Pet. Brief at 24-25. Instead, she accounts
for her forced early retirement in the pain and suffering award she seeks. Id. at 29-31.
In addition to her inability to continue working in a job she loved, Petitioner bases
the pain and suffering award she proposes upon the three trips to the emergency room
(“ER”) it took for her to obtain a final/accurate GBS diagnosis, her hospitalization followed
by inpatient and outpatient therapy, her continued need for Gabapentin and Tramadol to
control her pain, and her ongoing sequelae which included facial diplegia 5 and lower
extremity sensory loss. Pet. Brief at 27-29, 32-35. As comparable cases, she cites Gruba,
Enstrom, Merchant, Devlin, and Fedewa6 – cases involving past pain and suffering
awards ranging from $165,000.00 to $180,000.00. Brief at 36-40.
4 From July 2014 until September 2015, the SPU was overseen by former Chief Special Master Vowell. For
the next four years, until September 30, 2019, all SPU cases, including the majority of GBS claims, were
assigned to former Chief Special Master Dorsey. In early October 2019, the majority of SPU cases were
reassigned to me as the current Chief Special Master.
5 Facial diplegia is “paralysis affecting both sides of the face.” DORLAND’S ILLUSTRATED MEDICAL DICTIONARY
(“DORLAND’S “) at 524 (32nd ed. 2012).
6 Gruba v. Sec’y of Health & Hum. Servs., No. 19-1157V, 2021 WL 1925630 (Fed. Cl. Spec. Mstr. Aug. 7,
2020) (awarding $165,000.00 for actual pain and suffering); Enstrom v. Sec'y of Health & Hum. Servs., No.
20-2020V, 2023 WL 345657 (Fed. Cl. Spec. Mstr. Dec. 16, 2022) (awarding $170,000.00 for actual pain
and suffering); Merchant v. Sec'y of Health & Hum. Servs., No. 20-0450V, 2022 WL 17819548 (Fed. Cl.
Spec. Mstr. Nov. 7, 2022) (awarding $170,000.00 for actual pain and suffering); Devlin v. Sec’y of Health
& Hum. Servs., 19-0191V, 2020 WL 5512505 (Fed. Cl. Spec. Mstr. Aug. 7, 2020) (awarding $180,000.00
for actual pain and suffering); Fedewa v. Sec'y of Health & Hum. Servs., No. 17-1808V, 202 WL1915138
(Fed. Cl. Spec. Mstr. March 26, 2020) (awarding $180,000.00 for actual pain and suffering).
3
Emphasizing the shorter durations of Petitioner’s hospitalizations and inpatient
rehabilitation, her single course of IVIG therapy (albeit involving seven treatments), the
fact that most treatment occurred within the initial two months, and the limited treatment
required thereafter (only twice-yearly neurologic appointments), Respondent counters
that Petitioner should receive $120,000.00 for pain and suffering. He maintains that
Petitioner’s circumstances were less severe than the cases she cites. Id. at 9-10. And
Respondent argues I should rely on past proffered pain and suffering amounts when
assessing the appropriate amount in this case.
Regarding the disputed portion of the future expenses, Respondent insists
Petitioner should receive a more modest amount ($5,174.78), to cover the costs of
installing a walk-in shower, three grab bars, a raised toilet seat, a shower chair, and a
non-slip bathmat. Id. at 11-12; see ECF No. 62-1 (report from a life care planner employed
by Respondent). Characterizing Petitioner’s proposed renovations as “extensive” (Res.
Brief at 11), Respondent argues that all are not reasonably necessary for the purposes
listed in Section 15(a)(1)(A)(iii). Res. Brief at 10-12.
On reply, Petitioner criticizes Respondent’s failure to cite any past substantive
damages decisions to support the pain and suffering amount he proposes, arguing that it
“leaves his proposal unsupported and unpersuasive.” Petitioner’s Reply to Res. Brief
(“Pet. Reply”), filed Jan. 24, 2024, at 3, ECF No. 64. In addition to reiterating her previous
arguments and cited caselaw, Petitioner cites another, more recent comparable case,
Longo7 – involving an award of $160,000.00 - contending that her award should be
greater. Pet. Reply at 4-5.
III. Appropriate Compensation for Petitioner’s Pain and Suffering
In this case, awareness of the injury is not disputed. The record reflects that at all
times Petitioner was a competent adult with no impairments that would impact her
awareness of her injury. Therefore, I analyze principally the severity and duration of
Petitioner’s injury.
In performing this analysis, I have reviewed the record as a whole, including the
medical records, affidavits, and all assertions made by the parties in written documents.
I considered prior awards for pain and suffering in both SPU and non-SPU GBS cases
and rely upon my experience adjudicating these cases.8 However, I ultimately base my
7 Longo v. Sec'y of Health & Hum. Servs., No. 21-844V, 2023 WL 9326039 (Fed. Cl. Chief Spec. Mstr. Dec.
20, 2023) (awarding $160,000.00 for actual pain and suffering).
8 Statistical data for all GBS cases resolved in SPU by proffered amounts from inception through January
1, 2024 reveals the median amount awarded to be $171,133.72. The awards in these cases - totaling 364,
have typically ranged from $128,645.56 to $256,835.75, representing cases between the first and third
4
determination on the circumstances of this case.
The evidence shows that Petitioner – age 64 when vaccinated - suffered a
moderate GBS illness, involving common symptoms such as weakness, tingling, and
neurologic pain in her extremities, but also facial weakness, migraine pain, and urinary
incontinence. E.g., Exhibit 9 at 709, 1024-1026, 1534, 1537-1538 (describing placement
of Foley catheter). Initially prescribed a five-day course of IVIG therapy, Petitioner
required two additional days of treatment. Id. at 1568. Although she obtained some
improvement, Petitioner continued to require medication, including Gabapentin, to control
her pain. See, e.g., Exhibit 7 at 16-17. Following two hospitalizations in October 2019, for
four and eight days, respectively, Petitioner spent seven days in an inpatient rehabilitation
facility. Exhibit 9 at 2096, 2508-2513. She continued to use a walker but was able to have
her Foley catheter removed. Id. at 2096. From late October through December 2019,
Petitioner attended 19 PT sessions. Exhibit 6. Additionally, at the beginning of 2020,
Petitioner was forced to quit her job. Exhibit 30 at ¶¶ 1, 6 (Petitioner’s affidavit); Exhibit
41 at 29 (letter resignation letter with January 3, 2020 termination date).
Thereafter through 2022, Petitioner continued to report eye problems, facial
weakness, neuropathic pain in her feet, back pain, migraines, general weakness, and
fatigue. Exhibit 7 at 9, 12-13; Exhibit 10 at 13-14; Exhibit 15 at 26-30; Exhibit 36 at 18-19,
22-23; Exhibit 37 at 19-24; Exhibit 38 at 9; Exhibit 40 at 14-15; Exhibit 42 at 6-7. She
required Gabapentin throughout the day to control her neurologic pain. E.g., Exhibit 40 at
15. On October 18, 2021, her neurologist noted that Petitioner “has probably reached
maximum medical improvement.” Exhibit 6 at 22. In 2022 and 2023, two different
neurologists opined that Petitioner would require a walk-in shower, handrails and non-slip
bathmat. Exhibit 36 at 18-19; Exhibit 42 at 6-7.
Considering Petitioner’s ongoing sequelae, the amount proposed by Respondent
($120,000.00) is generally reasonable but low. As I have explained previously during
expedited “Motions Day” hearings, GBS pain and suffering awards should be higher than
in matters involving a less frightening and physically-alarming injury, such as SIRVA. And
as noted by Petitioner, I have routinely rejected Respondent’s contention that proffered
amounts offer better guidance than reasoned decisions by a judicial neutral. Sakovits v.
Sec’y of Health & Hum. Servs., No. 17-1028V, 2020 WL 3729420, at *4 (Fed. Cl. Spec.
quartiles and awards comprised of all categories of compensation – including lost wages. 47 cases include
the creation of an annuity to provide for future expenses.
Past pain and suffering amounts awarded in substantive decisions issued in 34 SPU GBS cases range
from $92,500.00 to $192,500.00, with an additional case involving annuity payments. The median amount
past pain and suffering award in these 35 cases was $165,000.00, with awards falling within the first and
third quartiles ranging from $155,000.00 to $180,000.00.
5
Mstr. June 4, 2020) (discussing the difference between cases in which damages are
agreed upon by the parties and cases in which damages are determined by a special
master).
Although all cases cited by Petitioner offer good comparisons to the circumstances
she experienced, I find Enstrom and Merchant are most similar to Petitioner’s facts and
circumstances. Both involved relatively short hospitalizations, IVIG therapy, similar
inpatient and/or outpatient therapy, and symptoms which continued for years. Enstrom,
2023 WL 345657, at *2-6; Merchant, 2022 WL 17819548, at *2-3. The Enstrom petitioner
was also forced to retire early and continued to require medication to control his pain.
Enstrom, 2023 WL 345657, at *4-5. And the Merchant petitioner continued to suffer from
urinary incontinence. Merchant, 2022 WL 17819548, at *3. Although not as obvious as
Petitioner’s continued facial weakness, this ongoing condition no doubt caused the
Merchant petitioner continued suffering. Given these similarities, I find that Petitioner
should be awarded the same amount as these two petitioners - $170,000.00 for her pain
and suffering.
IV. Appropriate Compensation for Petitioner’s Unreimbursed Expenses
Petitioner is also entitled to the renovation costs she seeks. Although the costs
Respondent disputes, such as a customized closet, would usually not be compensated,
they are necessary in this case.
The photographs submitted by Petitioner clearly shows that the easier, and
therefore cheapest, means of providing her with the needed walk-in shower is to add it to
the bathroom which currently does not contain a shower or tub. See Exhibit 43. Due to
the position of her current traditional tub and shower, the addition of a walk-in shower
would undoubtedly require the repositioning of the toilet, adding further expense (see id.
at 6), and the custom closet is required only because the addition of the walk-in shower
will encompass most of the current closet space (see id. at 1).
Although Respondent provides reasonable estimates for the additional equipment
Petitioner requires, he neglects to consider some installation costs. For example, the
space required for the walk-in shower and resulting mandated changes to the current
closet. See Exhibit 43 at 1. Thus, I find Petitioner is entitled to the full costs of the needed
renovations, as stated in the lower of the two estimates she obtained. Compare id. at 1
with id. at 2.
6
Conclusion
For all of the reasons discussed above and based on consideration of the record
as a whole, I find that $170,000.00 represents a fair and appropriate amount of
compensation for Petitioner’s past/actual pain and suffering.9 Additionally,
Petitioner is entitle to the full renovations costs she seeks, $21,480.00, as well as
the past and future expenses agreed upon by the parties.
I therefore award Petitioner a lump sum payment of $200,395.31,
representing compensation in the amounts of $170,000.00 for pain and suffering,
$7,506.81 for actual unreimbursable expenses, and $22,888.50 for projected
unreimbursable expenses in the form of a check payable to Petitioner. This amount
represents compensation for all damages that would be available under Section 15(a).
The Clerk of the Court is directed to enter judgment in accordance with this
Decision.10
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
9 Since this amount is being awarded for actual, rather than projected, pain and suffering, no reduction to
net present value is required. See Section 15(f)(4)(A); Childers v. Sec’y of Health & Hum. Servs., No. 96-
0194V, 1999 WL 159844, at *1 (Fed. Cl. Spec. Mstr. Mar. 5, 1999) (citing Youngblood v. Sec’y of Health &
Hum. Servs., 32 F.3d 552 (Fed. Cir. 1994)).
10 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
7